Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS‐CoV‐2
Here we present results from a survey on anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) seroprevalence in healthy blood donors from a low incidence coronavirus disease 2019 area (Apulia region, South Eastern Italy). Among 904 subjects tested, only in nine cases (0.99%) antibodies...
Saved in:
Published in | Journal of medical virology Vol. 93; no. 3; pp. 1739 - 1742 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.03.2021
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0146-6615 1096-9071 1096-9071 |
DOI | 10.1002/jmv.26425 |
Cover
Summary: | Here we present results from a survey on anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) seroprevalence in healthy blood donors from a low incidence coronavirus disease 2019 area (Apulia region, South Eastern Italy). Among 904 subjects tested, only in nine cases (0.99%) antibodies against SARS‐CoV‐2 were demonstrated. All the nine seropositive patients were negative for the research of viral RNA by reverse transcription polymerase chain reaction in nasopharyngeal swabs. These data, along with those recently reported from other countries, clearly show that we are very far from herd immunity and that the containment measures are at the moment the only realistic instrument we have to slow the spread of the pandemic.
Highlights
Seroprevalence for SARS‐CoV‐2 antibodies was studied in group of 904 healthy blood donors from South Eastern Italy.
Antibodies were detected only in nine (0.99%) cases. All the subjects were negative for viral RNA in nasopharyngeal swabs.
Herd immunity to the virus is far away to reach and is probably not a viable option to contain the spread of the pandemic |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0146-6615 1096-9071 1096-9071 |
DOI: | 10.1002/jmv.26425 |